Oseaspre Consultants
17.95
0.00(0.00%)
Market Cap₹0.40 Cr
PE Ratio-
Company Performance:
1D0.00%
1M0.00%
6M0.00%
1Y0.00%
5Y0.00%
View Company Insightsright
More news about Oseaspre Consultants
27May 26
Oseaspre Consultants recommends ₹87 dividend for FY26
Oseaspre Consultants Limited has recommended a dividend of ₹87 per equity share for the financial year ended March 31, 2026, subject to shareholder approval. The company reported a loss after tax of ₹18.27 lakh for FY26, compared to a profit of ₹3.98 lakh in FY25, due to nil revenue from operations. Total assets stood at ₹217.26 lakh, with cash and cash equivalents at ₹209.83 lakh. The statutory auditors issued an unqualified report, and the Board recommended the re-appointment of Mr. Jairaj Champaklal Bham.
 no imag found
16May 26
Oseaspre Consultants Approves FY26 Audited Results, Recommends ₹87 Dividend Per Share
Oseaspre Consultants held its board meeting on May 15, 2026, approving audited financial results for the quarter and full year ended March 31, 2026. The company reported a net loss after tax of ₹18.28 lakhs for FY26 against a net profit of ₹3.98 lakhs in FY25, with total income declining to ₹3.32 lakhs from ₹21.80 lakhs. Total comprehensive income for FY26 stood at ₹142.28 lakhs, supported by OCI of ₹160.56 lakhs from the sale of equity instruments. The board recommended a final dividend of ₹87 per equity share of ₹10 each, with the 44th AGM set for June 19, 2026, and a record date of June 12, 2026.
 no imag found
25Feb 26
Technojet Consultants Limited Divests 48,000 Equity Shares in INOR Medical Products
Technojet Consultants Limited announced the complete divestment of its 48,000 equity shares in INOR Medical Products Limited to Nowrosjee Wadia and Sons Limited through a regulatory filing. The transaction was disclosed under SEBI LODR Regulation 30, with Company Secretary Bhumika Ojha signing the disclosure on 25th February, 2026.
 no imag found
12Feb 26
Oseaspre Consultants Reports Q3FY26 Net Loss of ₹3.90 Lakh, Nine-Month Losses Widen
Oseaspre Consultants Limited reported a net loss of ₹3.90 lakh for Q3FY26 ended December 31, 2025, compared to ₹3.83 lakh loss in Q3FY25. Nine-month losses widened to ₹11.80 lakh from ₹10.27 lakh in the previous year. The company continues operating without revenue from operations, relying on other income of ₹0.55 lakh in Q3FY26. Total expenses for the quarter were ₹4.45 lakh, primarily employee benefits and other expenses.
 no imag found
1 Year Returns:0.00%
Industry Peers
Nesco
1,028.20
(-1.79%)
Indiabulls
29.43
(-0.61%)
SIS
412.85
(-1.49%)
Nirlon
606.80
(+0.30%)
Quess Corp
336.20
(+0.37%)
Indiqube Spaces
197.49
(+0.57%)
CMS Info Systems
220.69
(-0.34%)